Wednesday June 26, 2019
Home India Kirti Azad to...

Kirti Azad to file petition in high court regarding DDCA row

0
//

New Delhi: Kirti Azad, Former Indian cricketer requested for the appointment of an administrator to manage alleged financial irregularities in District Cricket Association (DDCA) and Delhi. He will also file a petition to the Delhi High Court regarding this.

The suspended Bharatiya Janata Party (BJP) Member of Parliament (MP) said the petition will also be impleading the central and state governments, Central Bureau of Investigation (CBI) and the Board of Control for Cricket in India (BCCI) besides all current and former DDCA officials, including former President and current Finance Minister Arun Jaitley.

“Once Justice Mukul Mudgal’s second report (on financial irregularities) on DDCA is submitted, we will attach it with our written petition, demanding the appointment of an administrator. We would also demand a time-bound Special Investigative Team (SIT) probe on mismanagement that has been going on in DDCA,” Azad told reporters at his residence here.

“We will file a petition against the Centre as the Ministry of Corporate Affairs and Urban Development is part of it. Concerning the state government, my complaint is against the Entertainment Tax Department for not raising questions (about irregularities). I also hope CBI starts an inquiry and not be a ‘caged parrot’ as the Supreme Court has termed it.”

Azad thanked and praised Justice Mudgal for the successful conduct last year of the India-South Africa Test at the Ferozeshah Kotla in New Delhi.

“For the first time since 1982, DDCA made profit from a Test match. The last time DDCA made profit was in 1982 in the Test match against England,” the 57-year-old said.

“That is also because BCCI organised the match with state association officials being behind bars after a CBI enquiry. They (DDCA) are so shameless that they even tried to hoodwink Justice Mudgal by submitting fake bills,” said the former all-rounder.

The 1983 World Cup-winner released a letter he wrote to Jaitley, dated September 13, 2015, where he alleged that the senior BJP leader played a “nefarious role” in DDCA affairs.

BJP has suspended Azad for his attack on Jaitley and served him a show cause notice, asking why he should not be expelled. Azad claimed that BJP will revoke his suspension as he had not targeted the party or the government but only corruption.

Azad was accompanied by former international cricketers Maninder Singh and Surinder Khanna and Dronacharya awardee cricket coach Gurcharan Singh.(IANS)

Next Story

Delhi High Court Directs Private Clinic to Continue with the Stem Cell Treatment

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained

0
Order
Delhi High Court. Source- Wikimedia

In an interim relief, the Delhi High Court has directed a private clinic to continue with the stem cell treatment being provided to the patients till its further orders.

The court’s interim direction came while hearing various petitions challenging the Centre’s decision to put stem cell therapy in the category of new drugs.

The petitioners were being provided stem cell treatment in Nutech Mediworld Clinic in Green Park here.

A Division Bench of justices Anu Malhotra and Talwant Singh said that all details of treatment being provided to the petitioners by the clinic be placed on record with an affidavit.

Representational image.

The court has sought the response of Centre and Indian Council of Medical Research to file reply on the petition and listed the matter for September 4 for further hearing.

The court has directed authorities concerned to examine whether the products being administered to the petitioners, prima facie, fall within the scope of the expression ‘new drugs’ as defined under Rule 2(1) (w) of New Drugs and Clinical Trial Rules, 2019 and communicate the view to the petitioners and the said clinic.

Also Read- LG CNS, Microsoft to Develop Cloud-based Enterprise Solutions

On account of the Centre’s fresh notification on ‘New Drugs and Clinical Rule 2019’, some medications used for the treatment would fall under the definition of ‘new drug’ and require approval from the authority concerned.

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained. (IANS)